Welcome To Nutrify Snips
Nutra News made Easy
-
Naturecan welcomes FDA approval of NMN for dietary supplements
The United States Food and Drug Administration (FDA) has officially recognized β-Nicotinamide Mononucleotide (NMN) as a lawful ingredient for inclusion in dietary supplements within the United States. This regulatory affirmation follows extensive discourse, scientific scrutiny, and industry advocacy, representing a significant advancement for the global longevity and nutritional science sector.The decision paves the way for… Read More
-
Urolithin A Shown to Rejuvenate Immune Cells and Combat Age Related Immune Decline
A new clinical study has found that Urolithin A (UA), a natural compound known for enhancing mitochondrial health, may help reverse age related immune decline. In a randomized, double blind, placebo controlled trial involving 50 healthy middle-aged adults, participants who received 1,000 mg of oral UA daily for four weeks showed significant improvements in immune… Read More
-
Plant-Based Supplement Reduces Oxidative Stress and Inflammation Post-Respiratory Viral Infection
In a randomized, double-blind study of individuals recovering from moderate COVID-19, a single 50 mg dose of a plant-based supplement (PB-Blend) significantly reduced mitochondrial ROS (−56%), iNOS (−60%), and NOX2-dependent ROS (−49%), while increasing bioavailable nitric oxide (+33%)—effects broader than those of 1000 mg Vitamin C. PB-Blend also improved inflammatory and immune markers, indicating it… Read More
-
γ-Tocotrienol – Vitamin E’s Stronger Ally Against Muscle Wasting
Recent research highlights γ-tocotrienol, a potent member of the vitamin E family, as a promising intervention against inflammation-induced muscle atrophy. In experimental models where muscle loss was triggered by lipopolysaccharide (LPS), γ-tocotrienol significantly preserved myotube size, suppressed atrophy-related genes such as MuRF-1 and Atrogin-1, and protected mitochondrial function, effects that were superior to those of… Read More
-
Associations Between Circulating NAD Levels, Metabolic Biomarkers, and Erythropoietic Responses Following Nicotinamide Mononucleotide Supplementation in Healthy Adults
A post hoc analysis of a randomized, double-blind NMN trial (300–900 mg/day for 60 days in healthy adults) provides new insight into how blood NAD levels relate to metabolic and hematological health. Participants with higher baseline NAD showed slightly higher hemoglobin, red blood cell count, and mean corpuscular hemoglobin concentration (markers linked to oxygen transport… Read More